Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories - Wikidata - wikimedia - TriplyDB

Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories

Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories

http://www.wikidata.org/entity/Q36847816

about

Pediatric Cancer Predisposition and Surveillance: An Overview, and a Tribute to Alfred G. Knudson Jr.Findings made in gene panel to whole genome sequencing: data, knowledge, ethics - and consequences?Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study.Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.From Sequence Data to Returnable Results: Ethical Issues in Variant Calling and Interpretation.Integrated tumor and germline whole-exome sequencing identifies mutations in MAPK and PI3K pathway genes in an adolescent with rosette-forming glioneuronal tumor of the fourth ventricle.A Pilot Study of Clinical Targeted Next Generation Sequencing for Prostate Cancer: Consequences for Treatment and Genetic Counseling.The ins and outs of molecular pathology reporting.Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.Ethical considerations in genomic testing for hematologic disorders.TMC-SNPdb: an Indian germline variant database derived from whole exome sequences Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings A method to reduce ancestry related germline false positives in tumor only somatic variant calling.Ethical frameworks for obtaining informed consent in tumour profiling: an evidence-based case for Singapore.Identification of potentially oncogenic alterations from tumor-only samples reveals Fanconi anemia pathway mutations in bladder carcinomas.Physician Experiences and Understanding of Genomic Sequencing in Oncology.The evidence for expanded genetic testing for pediatric patients with cancer.Precision oncology in the age of integrative genomics.Patient preferences regarding incidental genomic findings discovered during tumor profiling.Comprehensive genomic transcriptomic tumor-normal gene panel analysis for enhanced precision in patients with lung cancer.Main implications related to the switch to BRCA1/2 tumor testing in ovarian cancer patients: a proposal of a consensus.Additional germline findings from a tumor profiling program Familial pancreatic cancer Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap

P2860

Q30491849-04975515-39C0-4921-81F0-DD28417EE7B6 Q31114379-26EFE99A-01C6-43BA-BC08-21D554263BCA Q31157014-1891B8F8-86BC-4FEF-99E3-4343359C2173 Q34526631-D459858F-2408-451B-B8D1-0B4FD8A28D9E Q36312046-5FBD89B1-C6D7-4375-B5EC-B4AFB3FF1528 Q37212868-EECF7604-1195-4E5C-95CF-82C814743281 Q38850529-BF4B4CE2-19DD-412A-93E0-62EF239FFAF0 Q38875985-A06219DD-554D-4632-AE00-CE6CE29F0F1D Q39043523-823903B5-ED5C-4327-98B1-7D98F6ABD63C Q39363424-21925154-7D8E-4C9A-BDB9-F7845FA9B861 Q39611652-0A4D8F29-559B-4D40-8EB4-3A56D61255E9 Q39847275-44EF0A8A-17E8-4ADC-A1FB-D73F5F1AE559 Q42669039-36774358-AD3D-48FC-8D3E-C85A873FF061 Q45951380-CED1F0B9-ECA0-4999-A084-24846B7F7015 Q47161729-6E22E8CB-DD52-46B9-B671-5B86F60B83FE Q47726388-BC9E1655-7A53-41D4-B0D9-1CEE85FA7160 Q47736126-F0902D9D-F154-4FF8-AADB-A3BA1AAD7370 Q50105699-30082A31-A0C6-411B-BCB2-1D4F52AF63A3 Q53149929-15EE939B-6A2F-45F0-86D0-D2435E532233 Q55038408-94411906-5E9E-426C-97C2-E8E2630190D7 Q55313718-41F2354A-D142-40FB-8592-3FED82A405C7 Q57640179-957FAE0E-D667-4C19-8695-5410B2A9B2E5 Q57643835-510629A7-AD0A-4AB8-B51B-882EB86ADC9C Q57907545-18F131DF-0647-4361-BB91-1558E843EDB8

P2860

Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories

http://www.wikidata.org/entity/Q36847816

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Germline Findings in Tumor-Onl ...... or Clinicians and Laboratories

@en

type

label

Germline Findings in Tumor-Onl ...... or Clinicians and Laboratories

@en

prefLabel

Germline Findings in Tumor-Onl ...... or Clinicians and Laboratories

@en

P1433

Q36847816-B0717F94-9FFB-4F12-AA61-BFFC3D99DF3E

P1476

Q36847816-93326D33-8CF3-4776-8C81-C32313B155EA

P2093

Q36847816-307AB5BD-98D6-4073-9A08-C02F04382079

Q36847816-369B60BA-91F5-47A1-974E-001031C43B8F

Q36847816-BF0CCC2C-29BC-4333-95E4-89A4EB51B128

Q36847816-D453FA96-1D91-4A2E-9251-ABFB5042EDD3

Q36847816-D929DF36-E599-48F9-B396-078EA2A75E06

Q36847816-D93FC437-00D0-4406-8DDB-DDE9DAE2A445

Q36847816-F3EA5097-32DF-4A06-9556-7A9D5BDFFA04

Q36847816-F8BDB63B-2344-4AB5-9C25-C4B0FA83D871

P2860

Q36847816-0E39324E-D45F-436A-BB11-78D431C74D24

Q36847816-18F54C69-428F-4A58-895B-076E3785658F

Q36847816-1B7E8308-304F-4B99-ADD1-24348DC46689

Q36847816-257CE8F5-9411-47F0-BE48-56F86C057135

Q36847816-2839CD22-6B2A-45BD-9BC5-49E862766F28

Q36847816-36077A08-23F2-429E-BEF5-91E2FA4C9BE1

Q36847816-42F191A3-503E-4ED9-BB74-F1B6DA85D1D4

Q36847816-43BCD656-E2B6-488C-9610-4EC33107FEF5

Q36847816-5117AF2F-A864-49D7-942A-ACA04DCEB1E2

Q36847816-7A470C26-6258-4108-84AC-2A0E461CA097

P31

Q36847816-1BD3C3B4-961C-441B-ABEA-9282A3E4AA9F

P356

Q36847816-35BB3327-B0AB-4F41-B442-C694B2273B8F

P407

Q36847816-A6923D4A-E6CF-44F3-9840-A647FB8B8F32

P433

Q36847816-AAEB6021-50B7-4447-83E9-50FC5595BE9F

P478

Q36847816-BDCA3092-2DB4-4D5F-B117-AE661DBA766F

P577

Q36847816-687B1DCC-E379-4615-B5E9-DD65A652198C

P698

Q36847816-598B19F5-1083-4221-8A74-1188C2497315

P932

Q36847816-C595E56C-31D5-44D9-B00E-7783288F18DD

P356

P1433

Journal of the National Cancer Institute

P1476

Germline Findings in Tumor-Onl ...... or Clinicians and Laboratories

@en

P2093

Arul M Chinnaiyan

http://www.w3.org/2001/XMLSchema#string

Clinical Sequencing Exploratory Research Consortium Tumor Working Group

http://www.w3.org/2001/XMLSchema#string

D Williams Parsons

http://www.w3.org/2001/XMLSchema#string

Sameek Roychowdhury

http://www.w3.org/2001/XMLSchema#string

Sharon E Plon

http://www.w3.org/2001/XMLSchema#string

Stacy W Gray

http://www.w3.org/2001/XMLSchema#string

Steve Joffe

http://www.w3.org/2001/XMLSchema#string

Victoria M Raymond

http://www.w3.org/2001/XMLSchema#string

P2860

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

Germline and somatic polymerase ε and δ mutations define a new class of hypermutated colorectal and endometrial cancers

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

Clinical analysis and interpretation of cancer genome data

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.

Personalized oncology through integrative high-throughput sequencing: a pilot study.

Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations.

P31

scholarly article

P356

10.1093/JNCI/DJV351

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26590952

http://www.w3.org/2001/XMLSchema#string

P932

4849259

http://www.w3.org/2001/XMLSchema#string